entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
222699,TOB2P1,transcribed_pseudogene,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,47.7592246805599,0.164868083403832,0.293099173631412,0.562499311619221,0.573775872513193,0.961473650102656,NA
222699,TOB2P1,transcribed_pseudogene,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,28.4281170867726,0.0143655161635647,0.361226926381915,0.0397686747980034,0.96827755035553,0.995797437304219,patient-derived GBM cell lines (PDGCLs)
222699,TOB2P1,transcribed_pseudogene,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,59.1730424701822,-0.128897801558498,0.305436683684696,-0.422011527900034,0.673016603134105,0.933906632050025,A549
222699,TOB2P1,transcribed_pseudogene,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,49.5184318034887,-0.263050228738464,0.280678016465351,-0.937195695092626,0.348657903781503,0.986418245486816,A549
222699,TOB2P1,transcribed_pseudogene,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,117.81896992721,1.66729191011182,0.301919926291753,5.52229834774361,3.3459370709251e-08,2.33081379008511e-07,A549
222699,TOB2P1,transcribed_pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,20.2631171652003,0.367975901442493,0.436523065784995,0.842970120675676,0.399245154732447,1,sigmoid colon organoid
222699,TOB2P1,transcribed_pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,20.2631171652003,0.183367974450517,0.440109951252678,0.416641282317292,0.676940808906663,1,sigmoid colon organoid
